Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126928351 | 12692835 | 1 | I | 20160226 | 20160829 | 20160829 | PER | US-AJANTA PHARMA USA INC.-1056818 | AJANTA PHARMA | 20.00 | YR | M | Y | 82.00000 | KG | 20160829 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126928351 | 12692835 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | 201003 | .75 | MG | TABLET | BID | ||||||
| 126928351 | 12692835 | 2 | C | KEPPRA | LEVETIRACETAM | 1 | 0 | 3750 | MG | TABLET | |||||||||
| 126928351 | 12692835 | 3 | C | ZONEGRAN | ZONISAMIDE | 1 | 0 | 600 | MG | CAPSULE | |||||||||
| 126928351 | 12692835 | 4 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | 15 | MG | TABLET | |||||||||
| 126928351 | 12692835 | 5 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | 2.5 | MG | TABLET | |||||||||
| 126928351 | 12692835 | 6 | C | RANITIDINE. | RANITIDINE | 1 | 0 | 150 | MG | TABLET | QD | ||||||||
| 126928351 | 12692835 | 7 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | 30 | MG | CAPSULE | QD | ||||||||
| 126928351 | 12692835 | 8 | C | LIBRAX | CHLORDIAZEPOXIDE HYDROCHLORIDECLIDINIUM BROMIDE | 1 | 0 | CAPSULE | QD | ||||||||||
| 126928351 | 12692835 | 9 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | 0 | 17 | G | ||||||||||
| 126928351 | 12692835 | 10 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0 | 1 | DF | TABLET | QD | ||||||||
| 126928351 | 12692835 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | 1000 | MG | QD | |||||||||
| 126928351 | 12692835 | 12 | C | Omega 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | 300 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126928351 | 12692835 | 1 | Aggression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126928351 | 12692835 | Decreased interest | |
| 126928351 | 12692835 | Dyskinesia | |
| 126928351 | 12692835 | Off label use | |
| 126928351 | 12692835 | Product substitution issue | |
| 126928351 | 12692835 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126928351 | 12692835 | 1 | 20150923 | 0 |